Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
This is for the continued support of screening for Severe Combined Immunodeficiency (SCID) as part of the In-Service Evaluation (ISE). The seven regional newborn blood spot screening laboratories participating in the SCID ISE are: Great Ormond Street Hospital (GOSH) South West Thames South East Thames (Synnovis) Newcastle * Manchester Birmingham Sheffield * Newcastle lab's EQA tests the two SCID methodologies.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| GENQA LTD | SC639731 | £18,166 | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 | £18,166 initial term | GENQA LTD | active |
Government spending data: This supplier has received £662,393 in 1 payments (over £25k) from UK Health Security Agency (2022-04-22 to 2022-04-22). View full payment history →